Case Report: Exceptional Association of Leydig Cell Ovarian Tumor and Primary Hyperparathyroidism in a Postmenopausal Patient

    Elías Chuki, Zeina Hannoush
    Image of study
    TLDR A woman with a rare ovarian tumor and hyperparathyroidism improved after surgery, highlighting the need for reporting unusual cases to understand and manage rare diseases.
    The document is a case report of a 55-year-old postmenopausal woman who presented with symptoms of hyperandrogenism, including hirsutism and male pattern hair loss. She was found to have significantly elevated testosterone levels and mild hypercalcemia, consistent with primary hyperparathyroidism (PHPT). A hypoechoic lesion in the left ovary, identified on a pelvic ultrasound, was consistent with an ovarian Leydig cell tumor, a rare type of tumor that accounts for less than 0.1% of all ovarian tumors. After undergoing bilateral Hysterosalpingo-oophorectomy, the patient reported improvement of hyperandrogenism symptoms. This case is notable due to the rare association of ovarian Leydig cell tumor and PHPT, making it the second such case reported in literature. The authors conclude that careful identification and reporting of cases with unusual clinical presentations is essential to better understand the pathophysiology of uncommon diseases and guide their management.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 7 results

      community DHT levels after 4 weeks of Fina and 8 weeks of Fina + 4 weeks of Duta

      in Update  35 upvotes 5 years ago
      The user reported early stage diffuse hair thinning and increased DHT levels after 4 weeks on Finasteride and 8 weeks on Finasteride plus 4 weeks on Dutasteride, despite the medications being authentic and stored properly. They are considering increasing their Dutasteride dosage due to the lack of side effects and are unsure if the treatment is helping their hair.

      community Proposed new pathogenesis model for androgenetic alopecia (AGA)

      in Research/Science  8 upvotes 1 year ago
      The conversation discusses a new model for understanding androgenetic alopecia (AGA), linking it to dietary and lifestyle factors similar to PCOS, and highlighting the role of DHT, vascular damage, and inflammation. Treatments mentioned include Minoxidil, finasteride, and RU58841.

      community Spironolactine Update: 2 months (34, Female)

      in Female  23 upvotes 8 years ago
      A female user's experience using Spironolactone to treat Female Pattern Hair Loss (FPHL) and Androgenic Alopecia, as well as discussing the effectiveness of the drug at different dosages.

      community Quit vaping/smoking = 80% less loss

      in Research/Science  235 upvotes 11 months ago
      Quitting vaping significantly reduced hair loss for a user who was a heavy vaper and also taking finasteride. Some participants suggest nicotine's vasoconstrictive properties may worsen hair loss, while others share personal anecdotes of hair improvement after quitting smoking or vaping.

    Similar Research

    5 / 1000+ results